US$ 25.68
glp-1 discontinuation rates Treatment among users of receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes | Diabetologia ISPOR 2025: Exploring reasons for
Description
Mechanism information is for education only and is not a benefit claim

Among emerging anti-diabetic candidates, glucagon like peptide-1 (GLP-1) based therapies carry special cardiovascular implications, exerting both direct as well as indirect effects

Altimmune, Inc.(NASDAQ: ALT) announced plans to relocate its corporate headquarters from Gaithersburg, Maryland, to Morristown, New Jersey, later this year

elegans div-1 encodes the B subunit of the DNA polymerase alpha-primase complex and is highly expressed in proliferative germ cells

A degenerating fibroid can be extremely painful.

Explore GLP-1 receptor agonists for depression